Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 5/20 | 0.45 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.36 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.36 |
| ▸ | PDE2A | O00408 | 2/20 | 0.35 |
| ▸ | RAF1 | P04049 | 3/20 | 0.35 |
| ▸ | CASR | P41180 | 1/20 | 0.34 |
| ▸ | CDK8 | P49336 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6274761 | 0.93 | CETP (0.46) | CETPTLR7TLR8RAF1CASR | |
| SCHEMBL6567090 | 0.93 | CETP (0.46) | CETPTLR7TLR8RAF1CASR | |
| SCHEMBL6568317 | 0.89 | CETP (0.59) | CETPTLR7TLR8PDE2ACASR | |
| SCHEMBL6571478 | 0.89 | CETP (0.59) | CETPTLR7TLR8PDE2ACASR | |
| SCHEMBL5671276 | 0.88 | CETP (0.40) | CETPTLR7TLR8PDE2AKCNH2 | |
| SCHEMBL6567862 | 0.88 | CETP (0.40) | CETPTLR7TLR8PDE2AKCNH2 | |
| SCHEMBL6569007 | 0.88 | CETP (0.40) | CETPPDE2A | |
| SCHEMBL5668949 | 0.88 | CETP (0.40) | CETPPDE2A | |
| SCHEMBL6274625 | 0.86 | CETP (0.41) | CETPTLR7TLR8PDE2APPARG | |
| SCHEMBL994517 | 0.86 | CETP (0.41) | CETPTLR7TLR8PDE2APPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1469831-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A SOLID AMORPHOUS DISPERSION OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS | Pfizer Products Inc. (US) | 2004-10-27 | — | — | EP | disclosed |
| WO-2003063832-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A SOLID AMORPHOUS DISPERSION OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS | PFIZER PRODUCTS INC. (US) | 2003-08-07 | — | — | WO | disclosed |